Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 3 , Pages 274-279 , May 2010

Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view

  • Matthias May, M.D.

      Affiliations

    • Department of Urology, St. Elisabeth Hospital, Straubing, Germany
    • M.M. and S.B.-A. contributed equally to this work.
    • ,
  • Sabine Brookman-Amissah, M.D.

      Affiliations

    • Department of Urology, St. Elisabeth Hospital, Straubing, Germany
    • M.M. and S.B.-A. contributed equally to this work.
    • ,
  • Jan Roigas, M.D.

      Affiliations

    • Department of Urology, Vivantes Hospital Am Urban, Berlin, Germany
    • ,
  • Christian Peter Gilfrich, M.D.

      Affiliations

    • Department of Urology, St. Elisabeth Hospital, Straubing, Germany
    • ,
  • Sandra Pflanz, M.D.

      Affiliations

    • Department of Urology, Carl-Thiem Hospital, Cottbus, Germany
    • ,
  • Bernd Hoschke, M.D.

      Affiliations

    • Department of Urology, Carl-Thiem Hospital, Cottbus, Germany
    • ,
  • Sven Gunia, M.D.

      Affiliations

    • Institute of Pathology, HELIOS Hospital, Bad Saarow, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 33631 72312; fax: +49 33631 73010

Received 16 June 2008 ,Revised 14 July 2008 ,Accepted 14 July 2008.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96
  2. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology. 1998;51:203–205
  3. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol. 2001;166:1611–1623
  4. Wallen EM, Pruthi RS, Joyce GF, et al. Urologic Diseases in America Project. Kidney Cancer J Urol. 2007;177:2006–2018
  5. Lam JS, Shvarts O, Leppert JT, et al. Renal cell carcinoma 2005: New frontiers in staging, prognostication, and targeted molecular therapy. J Urol. 2005;173:1853–1862
  6. Horiguchi A, Ito K, Sumitomo M, et al. Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma. Urology. 2008;71:928–932
  7. Mancini V, Battaglia M, Ditonno P, et al. Current insights in renal cell cancer pathology. Urol Oncol. 2008;26:225–238
  8. Amin MB, Amin MB, Tamboli P, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26:281–291
  9. Klatte T, Chung J, Leppert JT, et al. Prognostic relevance of capsular involvement and collecting system invasion in Stages I and II renal cell carcinoma. BJU Int. 2007;99:821–824
  10. Jeong IG, Jeong CW, Hong SK, et al. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma. Urology. 2006;67:709–712
  11. Thomas DH, Verghese A, Kynaston HG, et al. Analysis of the prognostic implications of different tumor margin types in renal cell carcinoma. Histopathology. 2003;43:374–380
  12. Thoenes W, Störkel S, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas, and carcinomas) (The basic cytological and histopathological elements and their use for diagnostics). Pathol Res Pract. 1986;181:125–143
  13. American Joint Committee on Cancer. Kidney (AJCC Cancer Staging Manual). 6th ed. New York: Springer; 2002;p 323–5
  14. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumors. J Pathol. 1997;183:131–133

PII: S1078-1439(08)00166-X

doi: 10.1016/j.urolonc.2008.07.008

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 3 , Pages 274-279 , May 2010

Article Tools

* Image Usage & Resolution